Work

Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies

Year: 2006

Type: article

Source: Current Treatment Options in Oncology

DOI: 10.1007/s11864-006-0038-1

Authors: Thomas E. Witzig, Scott H. Kaufmann

Institution: Mayo Clinic

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Abbott Laboratories, Ariad Pharmaceuticals, National Institutes of Health, National Cancer Institute

Awards: G2190235346, Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer

OpenAlex ID: W1986603272

FWCI: 3.558

Cites: 61

Cited by: 74

Related to: 10